We compared the relative efficacy of normalization of plasma bicarbonate with acetazolamide (ACET) versus medroxyprogesterone acetate (MPA) in correcting chronic C02 retention during waking and sleeping states in patients with chronic obstructive airway disease (COPD). During placebo period, inspiratory effort (P0 -,) was high but insufficient to raise minute ventilation (VE) to the supernormal levels required for sufficient alveolar ventilation to normalize Paco2-Chronic ventilatory stimulation with either drug increased P0.i (5 to 42%), mean inspiratory flow (14 to 31%), tidal volume (11 to 22%), and VE (16 to 19%) in 11 of 15 patients. This resulted in significant correction of their C02 retention during waking and sleeping states (APaco2 = -5 to -16 mmHg), despite the presence of high inspiratory impedance, shortened inspiratory time, and nonuniform ventilation-perfusion ratio. The acute ventilatory response to exogenous
C02 was not a good predictor of the chronic ventilatory response to MPA or even of the chronic response mediated by the ACET-induced increase in hydrogen ion concentration ([H]). In 5 patients, ACET therapy was ineffective in correcting Paco2 despite increasing [H + ] in plasma andcerebrospinal fluid (CSF). However, these same patients did correct Paco2 with MPA coincident with an alkaline shift in plasma and CSF. The data confirm, using two means of chronic pharmacologic ventilatory stimulation, that insufficient inspiratory effort, as well as an abnormal breathing pattern, is a critical determinant of chronic C02 retention. They further show that ACETinduced acidification of plasma and cerebrospinal fluid does not cause sustained augmentation of ventilatory drive in a significant number of patients with COPD and chronic C02 retention.